Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.624
Sell
RSI(14)
39.186
Neutral
STOCH(KDJ)(9,3,3)
12.052
Oversold
ATR(14)
1.658
High Vlolatility
CCI(14)
-136.934
Sell
Williams %R
84.872
Oversold
TRIX(12,20)
-0.170
Sell
StochRSI(14)
23.631
Buy
Search
BCPE Perseus Investor Ord Shs (Proposed)
KLRAAdd to Watchlist
18.550USD
+0.230+1.26%
Close 07/17, 16:00（ET）Quotes delayed by 15 min
2.37BMarket Cap
--P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+1.26%
5 Days
-10.30%
1 Month
-6.78%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
Key Figures
17.900Open
18.870High
342.89KVolume
--P/E TTM
LossP/E Dynamic
--Dividend TTM
0.28%Turnover Ratio
18.320Prev. Close
17.610Low
4.85MTurnover
--P/E Static
-5.31P/B
0.00%Div Yield TTM
--ROA
28.22752wk High
0.92Volume Ratio
--Net Profit
123.68MShares
--EPS TTM
--Beta
--ROE
19.01052wk Low
6.88%Amplitude
--Gross Margin
2.37BMarket Cap
-1.84Reward/Risk
4.31%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
BCPE Perseus Investor Ord Shs (Proposed) News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
52.500
Target Price
+172.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
BCPE Perseus Investor Ord Shs (Proposed)
KLRA
6
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Indicators
Moving Average
Indicators
Value
Direction
MA5
--
--
MA10
--
--
MA20
--
--
MA50
--
--
MA100
--
--
MA200
--
--
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
BCPE Perseus Investor Ord Shs (Proposed) Info
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
Ticker SymbolKLRA
CompanyBCPE Perseus Investor Ord Shs (Proposed)
CEORenaud (Ron)
Websitehttps://www.kailera.com
Shareholders
Related Instruments
+0.83%
+1.22%
+0.08%
+0.69%
-0.11%
-0.28%
-1.42%
-2.27%
-1.48%
-0.36%
+0.39%
-0.08%
+1.02%
-1.91%
+0.02%
0.00%
-0.33%
+2.57%
+0.30%
-0.08%Popular Instruments
52153.200
-344.500 (-0.66%)
28587.500
-393.700 (-1.36%)
7454.300
-70.800 (-0.94%)
14401.000
-440.000 (-2.96%)
64922.000
-915.000 (-1.39%)
6228.900
-21.400 (-0.34%)
82.120
+2.841 (+3.58%)
333.740
+0.480 (+0.14%)
202.810
-4.590 (-2.21%)
4017.560
+42.000 (+1.06%)
FAQs
What is the current price of BCPE Perseus Investor Ord Shs (Proposed) (KLRA)?
The current price of BCPE Perseus Investor Ord Shs (Proposed) (KLRA) is 18.55.
What is the symbol of BCPE Perseus Investor Ord Shs (Proposed)?
The ticker symbol of BCPE Perseus Investor Ord Shs (Proposed) is KLRA.
What is the 52-week high of BCPE Perseus Investor Ord Shs (Proposed)?
The 52-week high of BCPE Perseus Investor Ord Shs (Proposed) is 28.23.
What is the 52-week low of BCPE Perseus Investor Ord Shs (Proposed)?
The 52-week low of BCPE Perseus Investor Ord Shs (Proposed) is 19.01.
What is the market capitalization of BCPE Perseus Investor Ord Shs (Proposed)?
The market capitalization of BCPE Perseus Investor Ord Shs (Proposed) is 2.29B.
Is BCPE Perseus Investor Ord Shs (Proposed) (KLRA) currently rated as Buy, Hold, or Sell?
According to analysts, BCPE Perseus Investor Ord Shs (Proposed) (KLRA) has an overall rating of STRONG BUY, with a price target of 52.50.
What is the Earnings Per Share (EPS TTM) of BCPE Perseus Investor Ord Shs (Proposed) (KLRA)?
The Earnings Per Share (EPS TTM) of BCPE Perseus Investor Ord Shs (Proposed) (KLRA) is -1.20.